International Journal of Radiation Oncology*Biology*PhysicsCancer BiologyPeer-reviewed journal article
Chromosomal instability increases radiation sensitivity
Pippa F. CosperiD, Maha ParachaiD, Kathryn M. JonesiD, Laura HrycyniakiD, Les HendersoniD, Ava Bryan, Diego Eyzaguirre, Emily McCunn, Elizabeth Boulanger, Jun Wan, Kwangok P. NickeliD, Vanessa L. Horner, Rong Hu, Paul M. HarariiD, Randall J. KimpleiD, Beth A. A. WeaveriD
Abstract
Continuous chromosome missegregation over successive mitotic divisions, known as chromosomal instability (CIN), is common in cancer. Increasing CIN above a maximally tolerated threshold leads to cell death due to loss of essential chromosomes. Here, we show in two tissue contexts that otherwise isogenic cancer cells with higher levels of CIN are more sensitive to ionizing radiation, which itself induces CIN. CIN also sensitizes HPV-positive and HPV-negative head and neck cancer patient derived xenograft (PDX) tumors to radiation. Moreover, laryngeal cancers with higher CIN prior to treatment show improved response to radiation therapy. In addition, we reveal a novel mechanism of radiosensitization by docetaxel, a microtubule stabilizing drug commonly used in combination with radiation. Docetaxel causes cell death by inducing CIN due to abnormal multipolar spindles rather than causing mitotic arrest, as previously assumed. Docetaxel-induced CIN, rather than mitotic arrest, is responsible for the enhanced radiation sensitivity observed in vitro and in vivo, challenging the mechanistic dogma of the last 40 years. These results implicate CIN as a potential biomarker and inducer of radiation response, which could provide valuable cancer therapeutic opportunities. Statement of SignificanceCancer cells and laryngeal tumors with higher chromosome missegregation rates are more sensitive to radiation therapy, supporting chromosomal instability as a promising biomarker of radiation response.
- organism: human
- research focus: cancer & tumor microenvironment
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 5
- FWCI
- 5.86
- Field percentile
- top 5%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The signaling axis CDK12-BRCA1 mediates dinaciclib associated radiosensitivity through p53-mediated cellular senescence.
Natalia García-Flores, Diego M. Fernández‐Aroca, … Ricardo Sánchez‐Prieto·Molecular OncologyPeer-reviewed·Dec 3, 2024
- Suppression of chromosome instability limits acquired drug resistance
E. A. Crowley, N. M. Hermance, … A. L. Manning·bioRxiv·Jul 10, 2020
- Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies
D. A. Lukow, E. L. Sausville, … J. M. Sheltzer·bioRxiv·Sep 25, 2020
- XRRA1 acts as a molecular brake on radiation-induced DNA damage signaling and immunogenic cell death in tumor cells.
Tanvi Qamar, Saba Ubaid, … Vivek Kumar Singh·bioRxiv·Apr 24, 2026
- BUB1 inhibition sensitizes lung cancer cell lines to radiotherapy and chemoradiotherapy
Shivani Thoidingjam, Sushmitha Sriramulu, … Shyam Nyati·bioRxiv·Apr 19, 2024
- Transient histone deacetylase inhibition reveals cell type invariant and specific effects of chromatin decondensation on irradiation response
Heng Li, Campbell Maben, … Rachel Patton McCord·Frontiers in Cell and Developmental BiologyPeer-reviewed·Aug 31, 2026